Comparison Overview

ketab corp

VS

International Pharmaceutical Quality

ketab corp

1419 Westwood Blvd, Los Angeles, CA, 90024, US
Last Update: 2025-11-28
Between 750 and 799

First Iranian Bookstore selling Persian Books, Music, Songs, Movies, Films (Farsi - Iranian) You can find your choice of Persian Books - Farsi Books - Iranian Books (ketabe Farsi) in www.ketab.com. Our collection of Persian Books - Farsi Books - Iranian Books Ketabe Gooya is a huge database which consists of all Persian or Farsi books printed in IRAN or outside of IRAN. You can easily see our list of Persian Books or KetabeGooya and search for your favorite (Farsi Books). We offer newly Printed Persian Books (Farsi Books ) on the top of our list. You have the option to browse our categorized Persian Books or Search our Persian Books - (Farsi Books - Iranian Books ) in both English and Farsi languages.

NAICS: 511
NAICS Definition:
Employees: 6
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

International Pharmaceutical Quality

undefined, Washington, D.C., undefined, undefined, US
Last Update: 2025-11-24
Between 750 and 799

INTERNATIONAL PHARMACEUTICAL QUALITY provides in-depth coverage of emerging drug, biologic and combination product CMC and GMP issues and developments, with a mission of helping advance and harmonize the quality regulatory process globally. Headquartered in Washington, IPQ is read by regulatory agencies and organizations, suppliers, consultants, law firms, and universities around the world. IPQ tracks the industry/regulator dialogue at key international forums along with the developments, initiatives, regulations, guidances and standards in the quality regulatory arena to create a uniquely valuable resource for the intelligence gathering, knowledge management, and external communication needs of the pharmaceutical community.

NAICS: 511
NAICS Definition:
Employees: 14
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/ketab-corp.jpeg
ketab corp
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/international-pharmaceutical-quality.jpeg
International Pharmaceutical Quality
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
ketab corp
100%
Compliance Rate
0/4 Standards Verified
International Pharmaceutical Quality
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for ketab corp in 2025.

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for International Pharmaceutical Quality in 2025.

Incident History — ketab corp (X = Date, Y = Severity)

ketab corp cyber incidents detection timeline including parent company and subsidiaries

Incident History — International Pharmaceutical Quality (X = Date, Y = Severity)

International Pharmaceutical Quality cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/ketab-corp.jpeg
ketab corp
Incidents

No Incident

https://images.rankiteo.com/companyimages/international-pharmaceutical-quality.jpeg
International Pharmaceutical Quality
Incidents

No Incident

FAQ

ketab corp company demonstrates a stronger AI Cybersecurity Score compared to International Pharmaceutical Quality company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, International Pharmaceutical Quality company has disclosed a higher number of cyber incidents compared to ketab corp company.

In the current year, International Pharmaceutical Quality company and ketab corp company have not reported any cyber incidents.

Neither International Pharmaceutical Quality company nor ketab corp company has reported experiencing a ransomware attack publicly.

Neither International Pharmaceutical Quality company nor ketab corp company has reported experiencing a data breach publicly.

Neither International Pharmaceutical Quality company nor ketab corp company has reported experiencing targeted cyberattacks publicly.

Neither ketab corp company nor International Pharmaceutical Quality company has reported experiencing or disclosing vulnerabilities publicly.

Neither ketab corp nor International Pharmaceutical Quality holds any compliance certifications.

Neither company holds any compliance certifications.

Neither ketab corp company nor International Pharmaceutical Quality company has publicly disclosed detailed information about the number of their subsidiaries.

International Pharmaceutical Quality company employs more people globally than ketab corp company, reflecting its scale as a Book and Periodical Publishing.

Neither ketab corp nor International Pharmaceutical Quality holds SOC 2 Type 1 certification.

Neither ketab corp nor International Pharmaceutical Quality holds SOC 2 Type 2 certification.

Neither ketab corp nor International Pharmaceutical Quality holds ISO 27001 certification.

Neither ketab corp nor International Pharmaceutical Quality holds PCI DSS certification.

Neither ketab corp nor International Pharmaceutical Quality holds HIPAA certification.

Neither ketab corp nor International Pharmaceutical Quality holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

ThingsBoard in versions prior to v4.2.1 allows an authenticated user to upload malicious SVG images via the "Image Gallery", leading to a Stored Cross-Site Scripting (XSS) vulnerability. The exploit can be triggered when any user accesses the public API endpoint of the malicious SVG images, or if the malicious images are embedded in an `iframe` element, during a widget creation, deployed to any page of the platform (e.g., dashboards), and accessed during normal operations. The vulnerability resides in the `ImageController`, which fails to restrict the execution of JavaScript code when an image is loaded by the user's browser. This vulnerability can lead to the execution of malicious code in the context of other users' sessions, potentially compromising their accounts and allowing unauthorized actions.

Risk Information
cvss4
Base: 6.2
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:N/VA:N/SC:H/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to to verify that the token used during the code exchange originates from the same authentication flow, which allows an authenticated user to perform account takeover via a specially crafted email address used when switching authentication methods and sending a request to the /users/login/sso/code-exchange endpoint. The vulnerability requires ExperimentalEnableAuthenticationTransfer to be enabled (default: enabled) and RequireEmailVerification to be disabled (default: disabled).

Risk Information
cvss3
Base: 9.9
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to sanitize team email addresses to be visible only to Team Admins, which allows any authenticated user to view team email addresses via the GET /api/v4/channels/{channel_id}/common_teams endpoint

Risk Information
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
Description

Exposure of email service credentials to users without administrative rights in Devolutions Server.This issue affects Devolutions Server: before 2025.2.21, before 2025.3.9.

Description

Exposure of credentials in unintended requests in Devolutions Server.This issue affects Server: through 2025.2.20, through 2025.3.8.